VEGF is a key angiogenic factor mediating neovascularization that has been shown to upregulate uPA but despite high expression of VEGF in SCLC, antiangiogenic therapeutics were not effective in prolonging the survival of the patients [28]. This evidence concerns the gene PLAU and small cell lung carcinoma.